Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Mahlangu%2C+J.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Mahlangu%2C+J.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2018
Mark Defining extended half-life rFVIII-A critical review of the evidence
Mahlangu, J. ; Young, G. ; Hermans, C. ; Blanchette, V. ; Berntorp, E. ^LU and Santagostino, E. (2018) In Haemophilia 24(3). p.348-358
- Contribution to journal › Article
Mark Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII
Hermans, C. ; Mahlangu, J. ; Booth, J. ; Schütz, H. ; Santagostino, E. ; Young, G. ; Lee, H. Y. ; Steinitz-Trost, K. N. ; Blanchette, V. and Berntorp, E. ^LU (2018) In Haemophilia 24(3). p.376-384
- Contribution to journal › Article
2008
Mark Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
Hoots, W. K. ; Ebbesen, L. S. ; Konkle, B. A. ; Auerswald, G. K. -H. ; Roberts, H. R. ; Weatherall, J. ; Ferran, J. -M. ; Ljung, Rolf ^LU ; Bianco, R. Perez and Ozelo, M. Castro , et al. (2008) In Haemophilia 14(3). p.466-466
- Contribution to journal › Article